MICHAEL F COLA Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for MICHAEL F COLA.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of MICHAEL F COLA. MICHAEL F COLA is Group President, Life Sciences in SAFEGUARD SCIENTIFICS INC ($SFE) and Managing Director in SAFEGUARD SCIENTIFICS INC ($SFE) and Chief Executive Officer in Aevi Genomic Medicine, LLC ($GNMX) and President and CEO in MEDGENICS, INC. ($MDGN) and Director in Vanda Pharmaceuticals Inc. ($VNDA) and Chief Executive Officer in Cerecor Inc. ($CERC) and in Sage Therapeutics, Inc. ($SAGE) and Director in Phathom Pharmaceuticals, Inc. ($PHAT).
Latest Insider Trading Transactions of MICHAEL F COLA
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, GNMX, CERC, PHAT, SFE, SAGE, VNDA
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jan 28 2021 | CERC | Cerecor Inc. | COLA MICHAEL F | Chief Executive Off ... | Option Exercise | A | 3.32 | 850,000 | 2,822,000 | 850,000 | |
| Jan 06 2021 | CERC | Cerecor Inc. | COLA MICHAEL F | Chief Executive Off ... | Option Exercise | A | 2.64 | 64,798 | 171,067 | 64,798 | |
| Oct 02 2020 | CERC | Cerecor Inc. | COLA MICHAEL F | Chief Executive Off ... | Option Exercise | A | 2.24 | 76,674 | 171,750 | 76,674 | |
| Jul 06 2020 | CERC | Cerecor Inc. | COLA MICHAEL F | Chief Executive Off ... | Option Exercise | A | 2.56 | 64,683 | 165,588 | 64,683 | |
| Jun 22 2020 | CERC | Cerecor Inc. | COLA MICHAEL F | Chief Executive Off ... | Option Exercise | A | 2.51 | 84,322 | 211,648 | 84,322 | |
| Jun 11 2020 | CERC | Cerecor Inc. | COLA MICHAEL F | Chief Executive Off ... | Buy | P | 2.50 | 100,000 | 250,000 | 175,746 | 75.7 K to 175.7 K (+132.02 %) |
| Jun 11 2020 | GNMX | Aevi Genomic Medic ... | COLA MICHAEL F | Chief Executive Off ... | Buy | P | 2.50 | 100,000 | 250,000 | 175,746 | 75.7 K to 175.7 K (+132.02 %) |
| Jun 11 2020 | SAGE | Sage Therapeutics, ... | COLA MICHAEL F | Option Exercise | A | 36.47 | 10,000 | 364,700 | 10,000 | ||
| May 22 2020 | PHAT | Phathom Pharmaceut ... | COLA MICHAEL F | Director | Option Exercise | A | 36.85 | 10,000 | 368,500 | 10,000 | |
| Feb 05 2020 | CERC | Cerecor Inc. | COLA MICHAEL F | Chief Executive Off ... | Option Exercise | A | 3.98 | 1,200,000 | 4,776,000 | 1,200,000 | |
| Feb 05 2020 | CERC | Cerecor Inc. | COLA MICHAEL F | Chief Executive Off ... | Grant | A | 0.00 | 75,746 | 0 | 75,746 | 0 to 75.7 K |
| Feb 05 2020 | CERC | Cerecor Inc. | COLA MICHAEL F | Chief Executive Off ... | Option Exercise | A | 3.98 | 1,200,000 | 4,776,000 | 1,200,000 | |
| Feb 05 2020 | CERC | Cerecor Inc. | COLA MICHAEL F | Chief Executive Off ... | Grant | A | 0.00 | 75,746 | 0 | 75,746 | 0 to 75.7 K |
| Feb 05 2020 | GNMX | Aevi Genomic Medic ... | COLA MICHAEL F | President and CEO | Option Exercise | D | 2.84 | 21,181 | 60,154 | 0 | |
| Feb 05 2020 | GNMX | Aevi Genomic Medic ... | COLA MICHAEL F | President and CEO | Option Exercise | D | 4.22 | 1,500,000 | 6,330,000 | 0 | |
| Feb 05 2020 | GNMX | Aevi Genomic Medic ... | COLA MICHAEL F | President and CEO | Option Exercise | D | 1.32 | 50,000 | 66,000 | 0 | |
| Feb 05 2020 | GNMX | Aevi Genomic Medic ... | COLA MICHAEL F | President and CEO | Option Exercise | D | 1.55 | 661,000 | 1,024,550 | 0 | |
| Feb 05 2020 | GNMX | Aevi Genomic Medic ... | COLA MICHAEL F | President and CEO | Option Exercise | D | 1.51 | 450,000 | 679,500 | 0 | |
| Feb 05 2020 | GNMX | Aevi Genomic Medic ... | COLA MICHAEL F | President and CEO | Option Exercise | D | 4.91 | 250,000 | 1,227,500 | 0 | |
| Feb 05 2020 | GNMX | Aevi Genomic Medic ... | COLA MICHAEL F | President and CEO | Option Exercise | D | 4.83 | 250,000 | 1,207,500 | 0 | |
| Feb 05 2020 | GNMX | Aevi Genomic Medic ... | COLA MICHAEL F | President and CEO | Option Exercise | D | 7.01 | 292,087 | 2,047,530 | 0 | |
| Feb 05 2020 | GNMX | Aevi Genomic Medic ... | COLA MICHAEL F | President and CEO | Option Exercise | D | 6.45 | 17,327 | 111,759 | 0 | |
| Feb 05 2020 | GNMX | Aevi Genomic Medic ... | COLA MICHAEL F | President and CEO | Sell | D | 0.00 | 2,267,859 | 0 | 0 | 2.3 M to 0 (-100.00 %) |
| Dec 09 2019 | GNMX | Aevi Genomic Medic ... | COLA MICHAEL F | President and CEO | Buy | P | 0.13 | 2,049,376 | 274,616 | 2,267,859 | 218.5 K to 2.3 M (+938.00 %) |
| Dec 09 2019 | GNMX | Aevi Genomic Medic ... | COLA MICHAEL F | President and CEO | Buy | P | 0.13 | 2,049,376 | 274,616 | 2,267,859 | 218.5 K to 2.3 M (+938.00 %) |
| Jun 17 2019 | VNDA | Vanda Pharmaceutic ... | COLA MICHAEL F | Director | Option Exercise | A | 15.04 | 10,000 | 150,400 | 10,000 | |
| Jun 17 2019 | VNDA | Vanda Pharmaceutic ... | COLA MICHAEL F | Director | Grant | A | 0.00 | 5,000 | 0 | 15,000 | 10 K to 15 K (+50.00 %) |
| Jun 06 2019 | SAGE | Sage Therapeutics, ... | COLA MICHAEL F | Option Exercise | A | 177.41 | 10,000 | 1,774,100 | 10,000 | ||
| Jun 18 2018 | GNMX | Aevi Genomic Medic ... | COLA MICHAEL F | President and CEO | Option Exercise | A | 1.55 | 661,000 | 1,024,550 | 661,000 | |
| Jun 15 2018 | VNDA | Vanda Pharmaceutic ... | COLA MICHAEL F | Director | Option Exercise | A | 18.30 | 10,000 | 183,000 | 10,000 | |
| Jun 15 2018 | VNDA | Vanda Pharmaceutic ... | COLA MICHAEL F | Director | Grant | A | 0.00 | 5,000 | 0 | 10,000 | 5 K to 10 K (+100.00 %) |
| Jun 08 2018 | SAGE | Sage Therapeutics, ... | COLA MICHAEL F | Option Exercise | A | 154.06 | 10,000 | 1,540,600 | 10,000 | ||
| May 16 2018 | GNMX | Aevi Genomic Medic ... | COLA MICHAEL F | President and CEO | Option Exercise | A | 1.51 | 450,000 | 679,500 | 450,000 | |
| Oct 18 2017 | GNMX | Aevi Genomic Medic ... | COLA MICHAEL F | President and CEO | Option Exercise | P | 2.84 | 21,181 | 60,154 | 21,181 | |
| Oct 18 2017 | GNMX | Aevi Genomic Medic ... | COLA MICHAEL F | President and CEO | Buy | P | 1.26 | 119,047 | 149,999 | 218,483 | 99.4 K to 218.5 K (+119.72 %) |
| Aug 15 2017 | GNMX | Aevi Genomic Medic ... | COLA MICHAEL F | President and CEO | Option Exercise | A | 1.32 | 500,000 | 660,000 | 500,000 | |
| Jun 19 2017 | VNDA | Vanda Pharmaceutic ... | COLA MICHAEL F | Director | Option Exercise | A | 13.75 | 10,000 | 137,500 | 10,000 | |
| Jun 19 2017 | VNDA | Vanda Pharmaceutic ... | COLA MICHAEL F | Director | Grant | A | 0.00 | 5,000 | 0 | 5,000 | 0 to 5 K |
| Jun 08 2017 | SAGE | Sage Therapeutics, ... | COLA MICHAEL F | Option Exercise | A | 72.74 | 14,000 | 1,018,360 | 14,000 | ||
| Feb 17 2017 | MDGN | Aevi Genomic Medic ... | COLA MICHAEL F | President and CEO | Option Exercise | A | 4.91 | 250,000 | 1,227,500 | 250,000 | |
| Jun 24 2016 | SAGE | Sage Therapeutics, ... | COLA MICHAEL F | Option Exercise | A | 28.35 | 13,922 | 394,689 | 13,922 | ||
| Apr 19 2016 | MDGN | MEDGENICS, INC. | COLA MICHAEL F | President and CEO | Option Exercise | A | 4.83 | 250,000 | 1,207,500 | 250,000 | |
| Oct 08 2015 | MDGN | MEDGENICS, INC. | COLA MICHAEL F | President and CEO | Buy | P | 6.50 | 38,460 | 249,990 | 99,436 | 61 K to 99.4 K (+63.07 %) |
| Jun 22 2015 | VNDA | Vanda Pharmaceutic ... | COLA MICHAEL F | Director | Option Exercise | A | 13.03 | 15,000 | 195,450 | 15,000 | |
| May 29 2015 | SAGE | Sage Therapeutics, ... | COLA MICHAEL F | Option Exercise | A | 73.13 | 13,922 | 1,018,116 | 13,922 | ||
| Dec 17 2004 | SFE | SAFEGUARD SCIENTIF ... | COLA MICHAEL F | Group President, Li ... | Option Exercise | A | 2.13 | 300,000 | 637,500 | 300,000 | |
| Jan 14 2004 | SFE | SAFEGUARD SCIENTIF ... | COLA MICHAEL F | Managing Director | Option Exercise | A | 0.00 | 100,000 | 0 | 100,000 |
Page: 1